Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

International Vaccine Institute Forms Partnerships To Expedite Addition Of HPV Vaccine To Asia Pacific Immunization Programs

This article was originally published in PharmAsia News

Executive Summary

SEOUL - The International Vaccine Institute held a symposium June 1-2 in Seoul to forge public-private partnerships to encourage governments to include the human papillomavirus to their immunization programs in Asia-Pacific and the Middle East

You may also be interested in...



Korea's LG Electronics Teams Up With International Vaccine Institute To Inoculate Kids In Kenya, Ethiopia

SEOUL - South Korean giant LG Electronics and the Seoul-based International Vaccine Institute have tightened cooperation in the area of vaccines aimed at Africa by signing a memorandum of understanding

Korea's LG Electronics Teams Up With International Vaccine Institute To Inoculate Kids In Kenya, Ethiopia

SEOUL - South Korean giant LG Electronics and the Seoul-based International Vaccine Institute have tightened cooperation in the area of vaccines aimed at Africa by signing a memorandum of understanding

GSK Cuts Price Of Cervarix Vaccine By 30% In Singapore

SHANGHAI - GlaxoSmithKline has announced the company recently reduced the price of its cervical cancer vaccine Cervarix by 30 percent in Singapore

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072074

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel